<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02554708</url>
  </required_header>
  <id_info>
    <org_study_id>PTW/PV201505-21</org_study_id>
    <nct_id>NCT02554708</nct_id>
  </id_info>
  <brief_title>pCONus Treatment of Wide Neck Intracranial Aneurysms</brief_title>
  <acronym>pToWin</acronym>
  <official_title>pToWin pCONus Treatment of Wide Neck Intracranial Aneurysms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Phenox GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Phenox GmbH</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess safety and efficacy of pCONus for the treatment of wide neck bifurcation aneurysms.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Title: pCONus Treatment of Wide Neck Intracranial Aneurysms

      Acronym: pToWin

      Device: pCONus Bifurcation Aneurysm Implant

      Study design: Prospective, multicenter, single-arm clinical investigation

      Purpose: To assess safety and efficacy of pCONus for the treatment of wide neck bifurcation
      aneurysms

      Duration of the study: 48 months

      Sample size: 100 evaluable patients

      Number of sites: &gt; 20

      Follow-up intervals: Two independent follow-ups (after 3-6 and 7-12 months) according to site
      specific standard
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Effectiveness Aneurysm occlusion (complete or neck remnant)</measure>
    <time_frame>Change from post-procedure to 3-6 and to 7-12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety Major stroke (ischemic or hemorrhagic) or neurological death related to the treatment of the target aneurysm</measure>
    <time_frame>within 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effectiveness</measure>
    <time_frame>at the time of the procedure</time_frame>
    <description>The &quot;Effectiveness endpoint&quot; is assessed throughout the intervention and is assessed as &quot;number/amount of&quot; for each following point:
To place pCONus in the desired location
Correct opening of the device (crown and shaft)
To perform aneurysm occlusion without obliteration of side branches and
To detach the device at the end of the procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety Intra-Procedural Complications</measure>
    <time_frame>at the time of the procedure</time_frame>
    <description>The &quot;Safety Intra-Procedural Complications&quot; endpoint is assessed throughout the intervention and is assessed as &quot;number/amount of&quot; for each following point:
Vessel perforation
Target aneurysm perforation with microcatheter or guidewire
Target aneurysm perforation with pCONus
Target aneurysm perforation with coils
Thromboembolism
Dissection of any access vessel</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety Post-Procedural Complications</measure>
    <time_frame>Change 1day post procedure up to 12months</time_frame>
    <description>The &quot;Safety Post-Procedural Complications&quot; endpoint is assessed throughout the intervention and is assessed as &quot;number/amount of&quot; for each following point:
Frequency of new parenchymal hemorrhage during the follow-up period
Frequency of new subarachnoid hemorrhage during the follow-up period
Frequency of new ischemic stroke on follow-up imaging
Rupture of the target aneurysm during the 12 months follow-up period
Rate of in-stent-stenosis
Rate of in-stent-thrombosis</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Intracranial Aneurysm</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>implantation of the pCONus Bifurcation Aneurysm Implant</intervention_name>
    <description>The device will be introduced through a regular microcatheter. After deployment of the device with the crown positioned in the aneurysm neck the aneurysm will be entered with a microcatheter to perform endovascular coil occlusion. After completion of the coiling procedure the pCONus device will be electrolytically detached from the insertion wire and only the crown and the shaft will remain as a permanent implant.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients harbouring an unruptured or ruptured bifurcation aneurysm, in which pCONus
        assisted coiling was judged to be the most appropriate treatment
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Aneurysm status:

               -  Unruptured aneurysm or

               -  Ruptured aneurysm with a Hunt and Hess grade of I - III.

          2. Age ≥18 and ≤ 80 years.

          3. The patient or legal representative provides written informed consent.

          4. The patient shows general compliance to follow the medical regimen and to attend
             follow-up examinations.

          5. The target aneurysm is located at one of the following cerebral vessel bifurcations:
             ICA terminus, AcomA, MCA or BA.

          6. Bifurcation wide neck aneurysm.

          7. The dome height should allow for safe deployment of the device crown. The fundus of
             the aneurysm should offer enough space for the crown of the pCONus to deploy.

        Exclusion Criteria:

          1. Vessel tortuosity precluding safe access and device deployment.

          2. Stenosis within the vascular access or target vessel ≥ 50 %.

          3. The target aneurysm has been previously treated with a stent or an intraaneurysmal
             implant beside coils.

          4. The treatment plan for the target aneurysm includes the use of additional intra-
             and/or extraaneurysmal temporary or permanent implants other than coils.

          5. More than one intracerebral aneurysm requires the treatment within the following 6
             months.

          6. Imaging evidence of an arteriovenous cerebrovascular malformation or a dural fistula.

          7. Any physical, medical or psychiatric condition of the patient interfering with the
             adherence of the requirements and follow-up regimen of the study.

          8. Any neurological disorder with progressive neurological symptoms, except attributable
             to a compressive effect of the target aneurysm.

          9. Current involvement in another study or trial.

         10. Women of child bearing potential or breast-feeding who cannot provide a negative
             pregnancy test.

         11. Known allergy to the components of device, study medication or contrast media that
             cannot be controlled medically.

         12. A medical condition interfering with a dual antiplatelet treatment.

         13. Known coagulopathy.

         14. Intracranial hemorrhage in the past 30 days apart from the target aneurysm.

         15. Ischemic stroke in the past 30 days.

         16. Myocardial infarction in the past 30 days.

         17. Major surgery in the past 30 days.

         18. Evidence of active infection at time of treatment.

         19. Co -morbidities or conditions with a life expectancy less than 12 months.

         20. Additional Exclusion criteria for ruptured aneurysm at the acute phase:

               1. The patient is clinically severely affected (Hunt and Hess grade IV and V).

               2. Severe vasospasm is proven during angiography.

               3. Proven parenchymal hemorrhage by CT or MRI.

               4. Proven subdural hematoma by CT or MRI.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alessandra Biondi, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Jean Minjoz (CHU Besançon), France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sabine Konopka</last_name>
    <phone>+49 0234 36919</phone>
    <phone_ext>0</phone_ext>
    <email>pToWin@phenox.info</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yvonne Treffner, Dr.</last_name>
    <phone>+49 0234 36919</phone>
    <phone_ext>0</phone_ext>
    <email>pToWin@phenox.info</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clínica La Sagrada Familia Department of Neuroscience (P.L.), Equipo de Neurocirugía Endovascular y Radiología Intervencionista</name>
      <address>
        <city>Buenos Aires</city>
        <state>Ciudad Autónoma de Buenos Aires</state>
        <zip>1642</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pedro Lylyk, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>LKH-Univ. Klinikum Graz Universitätsklinik für Radiologie</name>
      <address>
        <city>Graz</city>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hannes Deutschmann, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Christian Doppler Klinik Universitätsklinik für Neurologie der Paracelsus Medizinischen Privatuniversität</name>
      <address>
        <city>Salzburg</city>
        <zip>5020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Monika Killer-Oberpfalzer, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Pierre Wertheimer (HCL Groupement Hospitalier Est)</name>
      <address>
        <city>Bron cedex</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francis Turjman, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Gui de Chauliac (CHRU de Montpellier)</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain Bonafé, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>KRH Klinikum Nordstadt</name>
      <address>
        <city>Hannover</city>
        <state>Niedersachsen</state>
        <zip>30167</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jörg Hattingen, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vivantes Klinikum Neukölln</name>
      <address>
        <city>Berlin</city>
        <zip>12351</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annette Förschler, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Knappschaftskrankenhaus Bochum GmbH</name>
      <address>
        <city>Bochum</city>
        <zip>44892</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Freiburg</name>
      <address>
        <city>Freiburg</city>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>UKSH Universitätsklinikum Schleswig-Holstein Campus Kiel</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olav Jansen, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftsklinikum Mittelrhein gGmbH</name>
      <address>
        <city>Koblenz</city>
        <zip>56068</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan Felber, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UKSH Universitätsklinikum Schleswig-Holstein Campus Lübeck</name>
      <address>
        <city>Lübeck</city>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peter Schramm, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Osnabrück</name>
      <address>
        <city>Osnabrück</city>
        <zip>49076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan Lowens, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Knappschaftskrankenhaus Recklinghausen</name>
      <address>
        <city>Recklinghausen</city>
        <zip>45657</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Loehr, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Stuttgart Katharinenhospital</name>
      <address>
        <city>Stuttgart</city>
        <zip>70174</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Aguilar-Pérez, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>A.O.U. Policlinico G. Martino</name>
      <address>
        <city>Messina</city>
        <zip>98125</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>A.S.L. Napoli 1 Centro - P.O. San Giovanni Bosco</name>
      <address>
        <city>Napoli</city>
        <zip>80145</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>ULSS9 Ca' Foncello</name>
      <address>
        <city>Treviso</city>
        <zip>31100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Francesco Di Paola, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospitals Birmingham NHS Foundation Trust</name>
      <address>
        <city>Birmingham</city>
        <zip>B15 2TH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lamin, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Leeds Teaching Hospital NHS TRUST.</name>
      <address>
        <city>Leeds</city>
        <zip>LS1 3EX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anthony Goddard, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>James Cook University Hospital</name>
      <address>
        <city>Middlesbrough</city>
        <zip>TS4 3BW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rajeev Padmanabhan, Dr.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Austria</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>United Kingdom</country>
  </location_countries>
  <removed_countries>
    <country>Belgium</country>
  </removed_countries>
  <link>
    <url>http://phenox.net/</url>
    <description>phenox GmbH</description>
  </link>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 4, 2015</study_first_submitted>
  <study_first_submitted_qc>September 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 18, 2015</study_first_posted>
  <last_update_submitted>July 21, 2017</last_update_submitted>
  <last_update_submitted_qc>July 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aneurysm</keyword>
  <keyword>bifurcation</keyword>
  <keyword>wide neck</keyword>
  <keyword>pCONus</keyword>
  <keyword>intracerebral</keyword>
  <keyword>stroke</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Intracranial Aneurysm</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

